Well-documented racial inequities exist when it comes to prostate cancer. Extensive research has shown disparities in many measures, including screening, diagnostics, surveillance, and treatment.
The 2025 ASTRO annual meeting featured a prostate cancer radiation toxicity session and a presentation by Dr. Young Suk Kwon discussing an EPIC-26 longitudinal analyses of prostatic urethral lift ...
Associations between patient sociodemographic factors and non-treatment for localized prostate cancer. N represents the total number of biopsies in each variable category. The mean difference is the ...
No patients died of prostate cancer. The 5-year overall survival was 90%.
Introducing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia increases surgical volume in urology practices, according to a study published online Aug. 20 in the ...
Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases.
Pelvic clinical node-positive prostate cancer: Impact of radiotherapy and nodal disease burden. Validation of baseline health-related quality of life as prognostic indicator for survival outcome in ...
Holmium laser enucleation of the prostate (HoLEP) is safe and effective for treating symptomatic BPH independent of prostate size, according to a report in BJU International (2008;101:1536-1541). In ...
A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans ...
November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback